Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 519,294 | 464,662 | 498,533 | 397,328 | 378,283 |
| Cost of Goods | 385,709 | 320,425 | 315,034 | 287,094 | 323,849 |
| Gross Profit | 133,585 | 144,237 | 183,499 | 110,234 | 54,434 |
| Operating Expenses | 131,859 | 133,911 | 125,742 | 133,463 | 167,557 |
| Operating Income | 2,435 | 10,751 | 57,791 | -23,135 | -112,274 |
| Interest Expense | 34,895 | 36,669 | 39,899 | 38,829 | 42,209 |
| Other Income | 10,571 | 4,160 | -4,548 | 4,853 | 180,759 |
| Pre-tax Income | -21,889 | -21,758 | 13,344 | -57,111 | 26,276 |
| Income Tax | 144 | 2,186 | -108,173 | 7,792 | 389,668 |
| Net Income Continuous | -22,033 | -23,944 | 121,517 | -64,903 | -363,392 |
| Minority Interests | N/A | -11,948 | 6,450 | -32,775 | -98,386 |
| Net Income | $-22,033 | $-11,996 | $115,067 | $-32,128 | $-265,006 |
| EPS Basic Total Ops | -0.06 | -0.08 | 0.78 | -0.21 | -2.03 |
| EPS Basic Continuous Ops | -0.15 | -0.16 | 0.83 | -0.42 | -2.78 |
| EPS Diluted Total Ops | -0.06 | -0.08 | 0.78 | -0.21 | -2.03 |
| EPS Diluted Continuous Ops | -0.15 | -0.16 | 0.82 | -0.42 | -2.78 |
| EBITDA(a) | $64,029 | $71,033 | $117,878 | $32,797 | $-57,285 |